| Financial Year |
March 31 2023 |
| Monetary Funds |
2,560,867,287.84 |
| Held-for-trading Financial Assets |
594,460,733.47 |
| Notes Receivable |
-- |
| Accounts Receivable |
670,964,731.53 |
| Advances to Suppliers |
170,152,461.48 |
| Other Receivables |
34,057,965.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,463,832,001.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,354,227.69 |
| Total Current Assets |
5,671,791,518.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
100,928,346.89 |
| Investment Properties |
78,430,861.95 |
| Fixed Assetes |
2,369,178,661.58 |
| Under-construction Projects |
1,093,318,851.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
369,106,860.80 |
| R&D expenses |
-- |
| Goodwill |
25,487.37 |
| Long-Term Deferred and Prepaid Expenses |
8,951,335.39 |
| Deferred Income Tax Assets |
16,197,121.14 |
| Other Non-Current Assets |
70,542,743.68 |
| Sub-Total of Non-Current Assets |
4,106,680,270.21 |
| Total Assets |
9,778,471,788.41 |
| Short-Term Loans |
748,600,555.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
927,938,523.76 |
| Accounts Payable |
498,625,745.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
62,654,835.15 |
| Taxes Payable |
16,239,493.68 |
| Interest Payable |
-- |
| Dividend Payable |
1,112,902.48 |
| Other payables |
77,795,549.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
4,983,901.98 |
| Sub-Total of Current Liabilities |
2,392,921,117.45 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,241,543.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,974,247.80 |
| Total Liabilities |
2,428,895,365.25 |
| Paid-In Capital(Or Share Stock) |
558,823,500.00 |
| Capital Surplus |
3,607,480,841.60 |
| Surplus Reserve |
142,463,382.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,041,117,789.51 |
| Minority Stockholder's Interest |
-309,090.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,349,885,513.81 |
| Owner's Equity（Stockholder's Equity） |
7,349,576,423.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,778,471,788.41 |
